REG - NetScientific PLC - Issue of Equity

NetscientificAnnouncement

29/12/2021 08:50

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20211229:nRSc9323Wa&default-theme=true

RNS Number : 9323W  NetScientific PLC  29 December 2021

NetScientific plc

("NetScientific", the "Group" or the "Company")

 

Issue of Equity

 

NetScientific plc (AIM: NSCI), the international life sciences and
sustainability technology investment and commercialisation group, announces
the issue of shares.

 

As announced on 20 December 2021, the Company issued 146,542 shares as part of
the consideration of £192,390 for the acquisition of the majority stake in
Cetromed Limited.

 

An application has been made to the London Stock Exchange for the New Ordinary
Shares to be admitted to trading on AIM ("Admission") and it is expected that
Admission will become effective, and trading will commence at 8.00 a.m. on 30
December 2021. Following Admission, the total number of Ordinary Shares in
issue, and therefore the total number of voting rights, will be 21,121,853.

 

 

For more information, please contact:

 NetScientific                                     Via Walbrook PR
 Ilian Iliev, CEO

 WH Ireland (NOMAD, Financial Adviser and Broker)
 Chris Fielding / Darshan Patel                    +44 (0)20 7220 1666

 Walbrook PR
 Nick Rome/ Paul McManus/                          07748 325 236, 07980 541 893

 Nicholas Johnson                                  or 07884 664 686

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  IOEFEMSAUEFSELE